Free Trial

Zhengye Biotechnology (NASDAQ:ZYBT) Shares Down 7.2% - Here's What Happened

Zhengye Biotechnology logo with Medical background

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT - Get Free Report) shares were down 7.2% during mid-day trading on Monday . The stock traded as low as $11.48 and last traded at $12.51. Approximately 47,720 shares traded hands during trading, a decline of 84% from the average daily volume of 291,588 shares. The stock had previously closed at $13.48.

Zhengye Biotechnology Trading Down 7.1 %

The stock has a 50 day moving average of $6.57.

Zhengye Biotechnology Company Profile

(Get Free Report)

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.

Featured Articles

Should You Invest $1,000 in Zhengye Biotechnology Right Now?

Before you consider Zhengye Biotechnology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zhengye Biotechnology wasn't on the list.

While Zhengye Biotechnology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines